Cogent Biosciences, Inc.

COGT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$38.86-0.18%

2026-08-03

Financials

Valuation Metrics

Cogent Biosciences, Inc.'s Market Cap is $6.64B. At end of 2025 it was $2.40B. Ranked #1191 of 3,112 in US market (top 38%), #389 of 1,445 on NASDAQ (top 27%), #64 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 24%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$6.64B	US#1,191/3,112 Sec#64/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-354M	US—/3,112 Sec—/269
Total Assets	$903M	US#2,489/3,112 Sec#103/269
Net Assets	$608M	US#2,113/3,112 Sec#93/269
Value
P/B	10.93x	US#2,645/3,112 Sec#209/269
FCF Yield	-4.31%	US—/3,112 Sec—/269
Profitability
ROE	-58.30%	US#2,770/3,112 Sec#186/269
ROA	-39.24%	US#2,924/3,112 Sec#190/269
Financial Health
Debt Ratio	48.60%	US#547/3,112 Sec#137/269
Total Debt	$239M	US#2,120/3,112 Sec#85/269
FCF	$-286M	US#2,778/3,112 Sec#236/269
Cash	$241M	US#1,587/3,112 Sec#99/269
Current Ratio	15.14x	US#162/3,112 Sec#51/269
Performance
1Y Return	240.88%	US#85/3,112 Sec#25/269
1M Return	0.44%	US#1,583/3,112 Sec#70/269
From 52W High	-11.14%	US#1,130/3,112 Sec#62/269
1Y MDD	-26.34%	US#1,122/3,112 Sec#64/269
Trading
Volume	1,360,478 shares	US#1,206/3,112 Sec#118/269
Trading Value	$52M	US#1,317/3,112 Sec#78/269
Per Share
EPS	$-4.87	US—/3,112 Sec—/269
BPS	$9.41	US#1,835/3,112 Sec#69/269